Australia markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
39.190.00 (0.00%)
At close: 04:00PM EST
40.47 +1.28 (+3.27%)
After hours: 05:01PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
13,171
18,437
32,166
6,829
Cost of revenue
0
-
-
0
Gross profit
3,500
-
-
6,829
Operating expenses
Research development
92,824
75,463
50,523
38,845
Selling general and administrative
30,997
21,967
12,944
10,803
Total operating expenses
123,821
97,430
63,467
49,648
Operating income or loss
-110,650
-78,993
-31,301
-42,819
Interest expense
-
0
484
1,434
Total other income/expenses net
-7,870
-361
408
282
Income before tax
-114,079
-78,888
-29,094
-41,618
Income tax expense
-537
-6
-257
-23
Income from continuing operations
-113,542
-78,882
-28,837
-41,595
Net income
-113,542
-78,882
-28,837
-41,595
Net income available to common shareholders
-112,635
-77,087
-28,013
-40,027
Basic EPS
-
-1.77
-0.81
-1.54
Diluted EPS
-
-1.77
-0.81
-1.54
Basic average shares
-
43,627
34,542
25,939
Diluted average shares
-
43,627
34,542
25,939
EBITDA
-
-77,982
-27,966
-39,755